Skip to main content

Table 1 Demographic and pathologic data of adrenal tumors with myelolipomatous metaplasia

From: Adrenocortical adenoma with myelolipomatous metaplasia: a potential diagnostic pitfall: a case report and review of the literature

No.

Authors

Age

Sex

Adrenal pathology

Underlying disease

Other remarkable finding

1

Vyberg et al. [15]

31

F

ACA

2

Parenteau et al. [16]

28

M

Pigmented adrenal hyperplasia

3

Lamas et al. [17]

49

F

ACA

4

Lamas et al. [17]

67

F

ACA

HTN/DM

5

Montone et al. [20]

50

F

Adrenocortical neoplasm of UMP

6

Montone et al. [20]

56

F

Adrenocortical neoplasm of UMP

7

Montone et al. [20]

67

F

ACA

HTN

8

Inomoto et al. [21]

46

F

Black ACA

HTN

9

Yamada et al. [22]

72

F

ACA

Chronic hepatitis C

Concurrent endothelial cyst in adrenal

10

Shastri et al. [23]

40

F

Oncocytoma

HTN

Bilateral

11

Gurbuz et al. [24]

66

M

ACA

Goiter surgery

Nephrectomy

12

Yokoyama et al. [25]

34

F

ACC

Tumor site was ectopic adrenal (retroperitoneum)

13

Chandramahanti et al. [26]

66

F

ACA

HTN/DM

14

Hendry et al. [27]

60

F

ACA

HTN/hypothyroidism

Concurrent epithelioid angiosarcoma in adrenal

15

Kinebuchi et al. [28]

77

M

Cavernous hemangioma

History of gastric and rectal cancer

16

Dokmetas et al. [29]

53

F

ACA

HTN/DM

Concurrent schwannoma in adrenal

17

Larose et al. [30]

61

F

Macronodular adrenal hyperplasia

Bilateral

18

Fırat et al. [31]

62

F

ACA

19

Fırat et al. [31]

73

M

ACA

HTN

Concurrent endothelial cyst in the adrenal

20

Current case

45

F

ACA

HTN

ESRD

Concurrent pancreas cyst

  1. ACA adrenocortical adenoma, ACC adrenocortical carcinoma, UMP uncertain malignant potential, HTN hypertension, DM diabetes mellitus, ESRD end-stage renal disease